Journal Article

Retrospective analysis of Braak stage– and APOE4 allele–dependent associations between MR spectroscopy and markers of tau and neurodegeneration in cognitively unimpaired elderly

Ahmed, Wajiha, George, Ajax, Sheriff, Sulaiman, Boutajangout, Allal, Marsh, Karyn, Juchem, Christoph, Harvey, Patrick, Osorio, Ricardo, de Leon, Mony J., Vedvyas, Alok, Blessing, Esther M., Gajdošík, Mia, Zheng, Helena, Glodzik, Lidia, Babb, James S., Ahn, Sinyeob, Ghuman, Mobeena, Rusinek, Henry, Debure, Ludovic, Wisniewski, Thomas, Gajdošík, Martin, Chen, Anna M., Gaggi, Naomi, Kirov, Ivan I., Peralta, Rosemary

2024

Overview

•Hippocampal Glx correlated with CSF p-tau181, but not after covariate adjustment.•Hippocampal NAA correlated with volume, even after covariate adjustment.•Both correlations were driven by APOE4 carriers.•There were no correlations in regions affected at later Braak stages (IV-VI). The pathological hallmarks of Alzheimer's disease (AD), amyloid, tau, and associated neurodegeneration, are present in the cortical gray matter (GM) years before symptom onset, and at significantly greater levels in carriers of the apolipoprotein E4 (APOE4) allele. Their respective biomarkers, A/T/N, have been found to correlate with aspects of brain biochemistry, measured with magnetic resonance spectroscopy (MRS), indicating a potential for MRS to augment the A/T/N framework for staging and prediction of AD. Unfortunately, the relationships between MRS and A/T/N biomarkers are unclear, largely due to a lack of studies examining them in the context of the spatial and temporal model of T/N progression. Advanced MRS acquisition and post-processing approaches have enabled us to address this knowledge gap and test the hypotheses, that glutamate-plus-glutamine (Glx) and N-acetyl-aspartate (NAA), metabolites reflecting synaptic and neuronal health, respectively, measured from regions on the Braak stage continuum, correlate with: (i) cerebrospinal fluid (CSF) p-tau181 level (T), and (ii) hippocampal volume or cortical thickness of parietal lobe GM (N). We hypothesized that these correlations will be moderated by Braak stage and APOE4 genotype. We conducted a retrospective imaging study of 34 cognitively unimpaired elderly individuals who received APOE4 genotyping and lumbar puncture from pre-existing prospective studies at the NYU Grossman School of Medicine between October 2014 and January 2019. Subjects returned for their imaging exam between April 2018 and February 2020. Metabolites were measured from the left hippocampus (Braak II) using a single-voxel semi-adiabatic localization by adiabatic selective refocusing sequence; and from the bilateral posterior cingulate cortex (PCC; Braak IV), bilateral precuneus (Braak V), and bilateral precentral gyrus (Braak VI) using a multi-voxel echo-planar spectroscopic imaging sequence. Pearson and Spearman correlations were used to examine the relationships between absolute levels of choline, creatine, myo-inositol, Glx, and NAA and CSF p-tau181, and between these metabolites and hippocampal volume or parietal cortical thicknesses. Covariates included age, sex, years of education, Fazekas score, and months between CSF collection and MRI exam. There was a direct correlation between hippocampal Glx and CSF p-tau181 in APOE4 carriers (Pearson's r = 0.76, p = 0.02), but not after adjusting for covariates. In the entire cohort, there was a direct correlation between hippocampal NAA and hippocampal volume (Spearman's r = 0.55, p = 0.001), even after adjusting for age and Fazekas score (Spearman's r = 0.48, p = 0.006). This relationship was observed only in APOE4 carriers (Pearson's r = 0.66, p = 0.017), and was also retained after adjustment (Pearson's r = 0.76, p = 0.008; metabolite-by-carrier interaction p = 0.03). There were no findings in the PCC, nor in the negative control (late Braak stage) regions of the precuneus and precentral gyrus. Our findings are in line with the spatially- and temporally-resolved Braak staging model of pathological severity in which the hippocampus is affected earlier than the PCC. The correlations, between MRS markers of synaptic and neuronal health and, respectively, T and N pathology, were found exclusively within APOE4 carriers, suggesting a connection with AD pathological change, rather than with normal aging. We therefore conclude that MRS has the potential to augment early A/T/N staging, with the hippocampus serving as a more sensitive MRS target compared to the PCC. [Display omitted]

• Publisher: Elsevier Inc,Elsevier Limited,Elsevier
• Subject: Adiabatic / Aged / Aged, 80 and over / Aging / Alleles / Alzheimer Disease - diagnostic imaging / Alzheimer Disease - genetics / Alzheimer Disease - pathology / Alzheimer's disease / APOE genotype / Apolipoprotein E4 / Apolipoprotein E4 - genetics / Apolipoproteins / Aspartic Acid - analogs & derivatives / Aspartic Acid - metabolism / Asymptomatic / Biomarkers / Cerebrospinal fluid / Cognitive ability / Cognitively unimpaired / Cortex (cingulate) / Cortex (parietal) / Creatine / CSF p-tau181 / Dementia / Diagnostic tests / Female / Genotypes / Genotyping / Geriatrics / Glx / Health risk assessment / Hippocampus / Hippocampus - diagnostic imaging / Hippocampus - metabolism / Hippocampus - pathology / Humans / Hypotheses / Information processing / Inositol / Localization / Magnetic Resonance Spectroscopy / Male / Metabolism / Metabolites / Middle Aged / Neurodegeneration / Neurodegenerative diseases / Neuroimaging / Parietal lobe / Pathology / Precentral gyrus / Ratios / Retrospective Studies / Spectroscopy / Spectrum analysis / Substantia grisea / tau Proteins - cerebrospinal fluid / tau Proteins - genetics / tau Proteins - metabolism / Temporal lobe / Tomography